Drunk Elephant Protini: the refillable cream and its study footnote

The current manufacturer title identifies a firming refillable moisturizer. The FAQ retains Protini Polypeptide Cream wording and describes the same lightweight gel-cream. This naming distinction helps a reader recognize the product without assuming that every similarly named peptide preparation or another brand’s cream is the same formula. Protini product and FAQ

The practical product question can therefore remain about this gel-cream and the appearance goal attached to it. The Clinique regular cream review examines a separate moisturizer. A shared interest in peptides or firmness does not combine the products’ ingredient lists or study results.

Drunk Elephant presents a lightweight moisturizing texture and improvement in the appearance of firmness, texture and tone. The page also publishes a pH and free-from or dermatologist-tested positioning. These are manufacturer descriptions of the formula and its intended appeal. They are not a personal prediction about comfort or the outcome someone will notice. Manufacturer positioning Moisture, texture and tone give the discussion several concrete starting points. Identifying which one matters prevents a broad firmness slogan from standing in for every possible outcome.

AAD’s explanation of moisturizing offers useful context: trapped water can make some fine lines less noticeable. That helps separate a moisture-related appearance goal from a broader claim about structural changes. It does not independently verify Protini’s advertised percentages or prove that any one peptide caused a reported benefit. AAD fine-line context

The manufacturer highlights nine signal peptides and supplies a complete ingredient list. One declared name is Copper Palmitoyl Heptapeptide-14. It should be identified as written, rather than substituted with Copper Tripeptide-1 or treated as an undisclosed copper concentration. Naming the ingredient establishes a declaration, not a chemical assay or a measured skin response. Peptides and declaration

The nine-peptide story and the finished moisturizer’s reported outcome are different pieces of information. The First Aid Beauty Day Cream review explores a different ingredient-led cream. Its content does not supply missing information about Protini or turn an ingredient count into evidence of a hormonal preparation.

The page reports improvement in tone, radiance and luminosity for 96%, texture for 93% and hydration for 90%, with a clinical-study footnote naming 31 people after eight weeks. Those percentages are attached to specific outcomes. They should not be restated as one percentage of general rejuvenation or collagen replacement. Study outcomes

The public description does not provide the full protocol, control or raw measurements. FTC guidance emphasizes that evidence should apply to the actual product, claimed result and population. That makes the endpoint itself important when asking whether this study speaks to the concern being discussed. FTC evidence applicability

Near the outcome material, the page labels an image “After 4 weeks.” The reported percentages have the eight-week, 31-person footnote. The available wording does not reconcile the photograph with those results, so this review keeps both timepoints visible rather than assuming that the image proves every eight-week outcome. Photo and study labels

The blood-level claims guide offers wider context about matching a claim to what was actually established. It is not evidence for Protini. Here the specific question concerns what the photographed comparison represents and how it relates, if at all, to the stated clinical-study group.

The complete declaration and the current refillable title provide a more concrete identity than “peptide moisturizer.” They do not provide an assay for estriol, a hormone-free laboratory certification or an individualized assessment. The product can be discussed as a declared retail gel-cream without assigning an unstated prescription purpose to its ingredient names. Exact product ingredients

The medication-list questions guide provides related reading for an existing professional conversation. Manufacturer answers about mixing or compatibility should not become a personalized plan here. The useful information is the recognizable product, its complete declared formula and the specific question about its appearance role.

FDA’s intended-use discussion distinguishes cosmetic appearance purposes from medical treatment claims. It does not approve Protini or confirm its results. The distinction helps keep moisture, smoother-looking texture and the page’s firmness claims separate from a question about prescribed facial estriol or menopausal hormone treatment. FDA intended-use explanation

The provider-questions comparison provides related reading. Protini supplies a distinct gel-cream identity, full ingredient names and a small study summary. The meaningful unresolved question is which outcome answers the visible concern, with the four-week image and eight-week results still separate, rather than whether peptides imply a prescription-like effect.